Skip to main content
Top
Published in: European Radiology 8/2011

01-08-2011 | Oncology

Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility

Authors: C. Messiou, D. J. Collins, V. A. Morgan, N. M. deSouza

Published in: European Radiology | Issue 8/2011

Login to get access

Abstract

Objectives

To establish normal bone marrow values of apparent diffusion coefficient (ADC) over an age range, compare them with metastatic and myelomatous involvement, to establish reproducibility and to optimise b values.

Methods

The ADCs of bone marrow in 7 volunteers (mean age 29.7 years), 34 volunteers (mean age 63.3 years) and 43 patients with metastatic and myelomatous involvement (mean age 65.5 years) were measured. In 9 volunteers diffusion weighted MRI was repeated within 7 days. b values were derived to optimise contrast between normal and pathological marrow.

Results

The mean ADC of bone marrow in younger volunteers was significantly higher than that of older volunteers. The coefficient of reproducibility was 14.8%. The ADC mean of metastatic and myeloma bone disease was \( {1}0{54} + / - {456} \times {1}0 ^{-6} {\text{mm}}^{2}{\text{s}} ^{-1} \). An ADC threshold of 655 × 10−6 mm2s−1 separated normal and abnormal marrow with a sensitivity and specificity of 90% and 93% respectively. Contrast between normal and abnormal marrow was optimal at b = 1389 smm−2.

Conclusion

The reproducibility of ADC measurements in bone is equivalent to published data for soft tissue with a high sensitivity and specificity for separating abnormal from age matched normal bone marrow. A b value of around 1,400 smm−2 is optimal for imaging bone marrow.
Literature
1.
go back to reference Gauvain KM, McKinstry RC, Mukherjee P et al (2001) Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR 177:449–454PubMed Gauvain KM, McKinstry RC, Mukherjee P et al (2001) Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR 177:449–454PubMed
2.
go back to reference Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53–60PubMedCrossRef Sugahara T, Korogi Y, Kochi M et al (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53–60PubMedCrossRef
3.
go back to reference Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR 188:1622–1635PubMedCrossRef Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR 188:1622–1635PubMedCrossRef
4.
go back to reference Charles-Edwards EM, deSouza NM (2006) Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 6:135–143PubMedCrossRef Charles-Edwards EM, deSouza NM (2006) Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 6:135–143PubMedCrossRef
5.
go back to reference Messiou C, deSouza NM (2010) Diffusion weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring. Cancer Biomark 6:23–32 Messiou C, deSouza NM (2010) Diffusion weighted Magnetic Resonance Imaging of metastatic bone disease: A biomarker for treatment response monitoring. Cancer Biomark 6:23–32
6.
go back to reference Nonomumra Y, Yasumoto M, Yoshimura R et al (2001) Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging 13:757–760CrossRef Nonomumra Y, Yasumoto M, Yoshimura R et al (2001) Relationship between bone marrow cellularity and apparent diffusion coefficient. J Magn Reson Imaging 13:757–760CrossRef
7.
go back to reference Gutzeit A, Doert A, Froehlich JM et al (2010) Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 39:333–343PubMedCrossRef Gutzeit A, Doert A, Froehlich JM et al (2010) Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 39:333–343PubMedCrossRef
8.
go back to reference Goudarzi B, Kishimoto R, Komatsu S et al (2010) Detection of bone metastases using diffusion weighted magnetic resonance imaging:comparison with 11C-methionine PET and bone scintigraphy. Magn Reson Imaging 28:372–379PubMedCrossRef Goudarzi B, Kishimoto R, Komatsu S et al (2010) Detection of bone metastases using diffusion weighted magnetic resonance imaging:comparison with 11C-methionine PET and bone scintigraphy. Magn Reson Imaging 28:372–379PubMedCrossRef
9.
go back to reference Luboldt W, Küfer R, Blumstein N et al (2008) Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 249:1017–1025PubMedCrossRef Luboldt W, Küfer R, Blumstein N et al (2008) Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. Radiology 249:1017–1025PubMedCrossRef
10.
go back to reference Lee KC, Bradley DA, Hussain M et al (2007) A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia 9:1003–1011PubMedCrossRef Lee KC, Bradley DA, Hussain M et al (2007) A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia 9:1003–1011PubMedCrossRef
11.
go back to reference Lee KC, Sud S, Meyer CR et al (2007) An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res 67:3524–3528PubMedCrossRef Lee KC, Sud S, Meyer CR et al (2007) An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res 67:3524–3528PubMedCrossRef
12.
go back to reference Reischauer C, Froehlich JM, Koh DM et al (2010) Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps – initial observations. Radiology 257:523–531PubMedCrossRef Reischauer C, Froehlich JM, Koh DM et al (2010) Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps – initial observations. Radiology 257:523–531PubMedCrossRef
13.
go back to reference Reese TG, Heid O, Weisskoff RM, Wedeen VJ (2003) Reduction of eddy-current induced distortion in diffusion MRI using twice refocused spin echo. Magn Reson Med 49:177–182PubMedCrossRef Reese TG, Heid O, Weisskoff RM, Wedeen VJ (2003) Reduction of eddy-current induced distortion in diffusion MRI using twice refocused spin echo. Magn Reson Med 49:177–182PubMedCrossRef
14.
go back to reference Kingsley P (2006) Introduction to diffusion tensor imaging mathematics: part III. Tensor calculation, noise, simulations and opimisation. Concepts Magn Reson 28A:155–179CrossRef Kingsley P (2006) Introduction to diffusion tensor imaging mathematics: part III. Tensor calculation, noise, simulations and opimisation. Concepts Magn Reson 28A:155–179CrossRef
15.
go back to reference Koh DM, Blackledge M, Collins D et al (2009) Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 19:2728–2738PubMedCrossRef Koh DM, Blackledge M, Collins D et al (2009) Reproducibility and changes in the apparent diffusion coefficients of solid tumours treated with combretastatin A4 phosphate and bevacizumab in a two-centre phase I clinical trial. Eur Radiol 19:2728–2738PubMedCrossRef
16.
go back to reference Hatipoglu GH, Slevi A, Ciliz D, Yuksel E (2007) Quantitative and diffusion MR imaging as a new method to assess osteoporosis. AJNR 28:1934–1937PubMedCrossRef Hatipoglu GH, Slevi A, Ciliz D, Yuksel E (2007) Quantitative and diffusion MR imaging as a new method to assess osteoporosis. AJNR 28:1934–1937PubMedCrossRef
17.
go back to reference Yeung DK, Wong SY, Griffith JF, Lau EM (2004) Bone marrow diffusion in osteoporosis: evaluation with quantitative MR diffusion imaging. J Magn Reson Imaging 19:222PubMedCrossRef Yeung DK, Wong SY, Griffith JF, Lau EM (2004) Bone marrow diffusion in osteoporosis: evaluation with quantitative MR diffusion imaging. J Magn Reson Imaging 19:222PubMedCrossRef
18.
go back to reference Griffith JF, Yeung DKW, Antonio GE et al (2006) Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 241:831–838PubMedCrossRef Griffith JF, Yeung DKW, Antonio GE et al (2006) Vertebral marrow fat content and diffusion and perfusion indexes in women with varying bone density: MR evaluation. Radiology 241:831–838PubMedCrossRef
19.
go back to reference Tang GY, Lv ZW, Tang RB et al (2010) Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis. Clin Rad 65:377–381CrossRef Tang GY, Lv ZW, Tang RB et al (2010) Evaluation of MR spectroscopy and diffusion-weighted MRI in detecting bone marrow changes in postmenopausal women with osteoporosis. Clin Rad 65:377–381CrossRef
20.
go back to reference Wilkins BS (1992) Histology of normal haemopoiesis: bone marrow histology. I. J Clin Pathol 45:645–649PubMedCrossRef Wilkins BS (1992) Histology of normal haemopoiesis: bone marrow histology. I. J Clin Pathol 45:645–649PubMedCrossRef
21.
go back to reference Griffith JF, Yeung DK, Antonio GE et al (2005) Vertebral bone mineral density, marrow perfusion and fat content in normal and osteoporotic males: analysis using dynamic contrast enhanced NR and MR spectroscopy. Radiology 236:945–951PubMedCrossRef Griffith JF, Yeung DK, Antonio GE et al (2005) Vertebral bone mineral density, marrow perfusion and fat content in normal and osteoporotic males: analysis using dynamic contrast enhanced NR and MR spectroscopy. Radiology 236:945–951PubMedCrossRef
22.
go back to reference Baur A, Huber A, Ertl-Wagner B et al (2001) Diagnostic value of increased diffusion weighting of a steady-state free precession sequence for differentiating acute benign osteoporotic fractures from pathologic vertebral compression fractures. AJNR 22:366–372PubMed Baur A, Huber A, Ertl-Wagner B et al (2001) Diagnostic value of increased diffusion weighting of a steady-state free precession sequence for differentiating acute benign osteoporotic fractures from pathologic vertebral compression fractures. AJNR 22:366–372PubMed
23.
go back to reference Herneth AM, Philipp MO, Naude J et al (2002) Vertebral metastases: assessment with apparent diffusion coefficient. Radiology 225:889–894PubMedCrossRef Herneth AM, Philipp MO, Naude J et al (2002) Vertebral metastases: assessment with apparent diffusion coefficient. Radiology 225:889–894PubMedCrossRef
Metadata
Title
Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility
Authors
C. Messiou
D. J. Collins
V. A. Morgan
N. M. deSouza
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
European Radiology / Issue 8/2011
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-011-2116-4

Other articles of this Issue 8/2011

European Radiology 8/2011 Go to the issue